R&D/ Views & Analysis/ Views and analysis Q&A: Novartis’ Eric Hughes on transplantation George Underwood kidney disease, liver disease, Novartis, transplantation 0 Comment With approximately 3.2 million people worldwide living with end-stage renal disease, there is immense pressure on healthcare systems Share X Q&A: Novartis’ Eric Hughes on transplantation https://pharmaphorum.com/r-d/views-analysis-r-d/novartis-eric-hughes-transplantation/